Entourage

Meet Entourage
in Amsterdam

Strategic conversations on biosimilar access, EU pharmaceutical policy, and market dynamics — at the Biosimilar Medicines Conference 2026.

📍Hilton Amsterdam Airport Schiphol
📅7–8 May 2026
🤝On-site meetings available
See Who Is Attending

Turning Conversations
into Action

The Biosimilar Medicines Conference brings together key stakeholders shaping the future of biosimilar access, policy, and industrial resilience. With EU pharmaceutical legislation under revision and global trade pressures reshaping healthcare, direct dialogue with experienced advisors has never been more valuable.

Regulatory strategy & EU pharmaceutical legislation

Navigating the evolving EU regulatory landscape, from biosimilar approval pathways to the Critical Medicines Act.

Biosimilar market access & commercialisation

Strategic positioning, payer engagement, and market entry to drive sustainable biosimilar uptake.

Supply chain resilience & industrial policy

Addressing vulnerabilities in biosimilar supply chains and aligning with emerging industrial policy frameworks.

Health technology assessment & outcomes

Demonstrating value through patient outcomes data and supporting HTA processes across EU markets.

Strategic coalitions & stakeholder engagement

Building cross-value-chain alliances to unlock the full potential of biosimilar medicines.

Ready to connect?

Schedule a focused 30-minute conversation with our team at the Biosimilar Medicines Conference 2026.

View Attendees →

Your Contacts in Amsterdam

Book a focused 30-minute on-site meeting with one of our consultants during the Biosimilar Medicines Conference in Amsterdam.

Andreas Weirich

Andreas Weirich

Head of Pharma Sales

Focus Areas

Market access & positioningBiosimilar commercialisationStrategic partnershipsSupply chain excellence
"

The Biosimilar Medicines Conference is a key platform to connect with decision-makers shaping the future of access, affordability, and industrial resilience across the biosimilar value chain.

Lena Pauli

Lena Pauli

Principal Consultant

Focus Areas

Regulatory strategy & complianceEU pharmaceutical legislationHealth technology assessmentStakeholder engagement
"

With biosimilar policy intersecting industrial strategy, regulatory evolution, and patient access, this conference creates the ideal space for genuine dialogue between all stakeholders in the value chain.

30-minute meetings · Hilton Amsterdam Airport Schiphol · 7–8 May 2026